These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7460781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].
    Mazo EB, Babanina GA.
    Urologiia; 2007; (3):15-9. PubMed ID: 17722614
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].
    Mazo EB, Krivoborodov GG, Shkol'nikov ME, Babanina GA, Kozyrev SV, Korshunov ES.
    Urologiia; 2005; (4):56-9. PubMed ID: 16158750
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of trospium chloride on the lower urinary tract function].
    Suzuki T, Nishizawa O, Sugaya K, Kohama T, Matsuzaki A, Fukuda T, Tsukada T, Harada T, Tsuchida S.
    Hinyokika Kiyo; 1990 Sep; 36(9):1047-51. PubMed ID: 2239610
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG, Kadykov AS, Shvedkov VV, Timerbaeva SL, Polevaia EV, Mulach AN.
    Urologiia; 2009 Sep; (5):24-9. PubMed ID: 20213911
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical trial to evaluate trospium chloride (Uraplex) effectiveness and tolerance in patients with detrusor instability incontinence and its impact on quality of life].
    Fuertes ME, García Matres MJ, González Romojaro V, de la Rosa S, Anguera Vila A, de la Peña J, Leiva Galvis O, Sánchez Chapado M.
    Arch Esp Urol; 2000 Mar; 53(2):125-36. PubMed ID: 10802918
    [Abstract] [Full Text] [Related]

  • 14. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P, Martínez MJ, Muguerza R, Jaureguizar E.
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.
    Amend B, Hennenlotter J, Schäfer T, Horstmann M, Stenzl A, Sievert KD.
    Eur Urol; 2008 May; 53(5):1021-8. PubMed ID: 18243516
    [Abstract] [Full Text] [Related]

  • 17. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study.
    Ozdedeli S, Karapolat H, Akkoc Y.
    Clin Rehabil; 2010 Apr; 24(4):342-51. PubMed ID: 20212061
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Therapy of detrusor hyperactivity with propiverin (mictonorm)].
    Wehnert J, Kelly LU, Sage S.
    Z Urol Nephrol; 1981 Nov; 74(11):827-32. PubMed ID: 7324590
    [Abstract] [Full Text] [Related]

  • 20. Trospium chloride (Sanctura): another anticholinergic for overactive bladder.
    Med Lett Drugs Ther; 2004 Aug 02; 46(1188):63-4. PubMed ID: 15289745
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.